Represented clients in the New Jersey Multi-County Stryker Rejuvenate and ABG II Modular Hip Stem litigation, including two Plaintiffs who resolved their cases through the NJ Court’s bellwether mediation program. Assisted in developing a global settlement program for both the multi-county litigation and the federal multi-district litigation, a program valued at over $1 billion. Appointed to the settlement negotiation team and will serve as a member of the Plaintiffs’ Settlement Oversight Committee.
Trial Counsel in Whitely v. Pfizer Inc. Represented Plaintiff in first Chantix bellwether trial. Case confidentially settled 3 days prior to jury selection. Lead to settlement of virtually every case pending in the MDL.
Trial Counsel in Charbonneau v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc. Represented plaintiffs in first Mirapex products liability bellwether trial. On July 30, 2008, jury returned a verdict in favor of plaintiffs for $8,279,300, including $7.8 million in punitive damages for failing to warn of risk of compulsive behaviors, including pathological gambling, from the Parkinson’s drug Mirapex.
Trial Counsel in Zwayer v. Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc. Represented plaintiffs in second Mirapex bellwether trial. Case was confidentially settled prior to closing argument.
Confidentially settled more than 280 Mirapex cases represented by Robins Kaplan LLP during Fall of 2008.
Lead trial counsel in first two Chantix MDL bellwether trials; confidentially settled prior to trial, leading to settlement of entire MDL.
Trial counsel, State of Minnesota and Blue Cross & Blue Shield of Minnesota v. Philip Morris, et al. In May 1998, the case settled after a four month trial when Tobacco Companies agreed to pay the State and Blue Cross & Blue Shield more than $6.6 billion.